Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Amortizatization of Intangibles (2020 - 2025)

Historic Amortizatization of Intangibles for Relay Therapeutics (RLAY) over the last 6 years, with Q3 2025 value amounting to $1.1 million.

  • Relay Therapeutics' Amortizatization of Intangibles fell 6535.56% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year decrease of 5455.34%. This contributed to the annual value of $12.3 million for FY2024, which is 1441.98% up from last year.
  • As of Q3 2025, Relay Therapeutics' Amortizatization of Intangibles stood at $1.1 million, which was down 6535.56% from $1.4 million recorded in Q2 2025.
  • Relay Therapeutics' Amortizatization of Intangibles' 5-year high stood at $3.7 million during Q4 2023, with a 5-year trough of -$681000.0 in Q4 2021.
  • Its 5-year average for Amortizatization of Intangibles is $1.3 million, with a median of $1.4 million in 2025.
  • As far as peak fluctuations go, Relay Therapeutics' Amortizatization of Intangibles plummeted by 827500.0% in 2021, and later surged by 94588.24% in 2023.
  • Quarter analysis of 5 years shows Relay Therapeutics' Amortizatization of Intangibles stood at -$681000.0 in 2021, then skyrocketed by 156.53% to $385000.0 in 2022, then skyrocketed by 852.99% to $3.7 million in 2023, then crashed by 40.56% to $2.2 million in 2024, then crashed by 49.52% to $1.1 million in 2025.
  • Its Amortizatization of Intangibles was $1.1 million in Q3 2025, compared to $1.4 million in Q2 2025 and $1.6 million in Q1 2025.